pHAGE-GATA3 Citations (3)

Originally described in: Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. PubMed Journal

---

Articles Citing pHAGE-GATA3

Articles
Systematic characterization of mutations altering protein degradation in human cancers. Tokheim C, Wang X, Timms RT, Zhang B, Mena EL, Wang B, Chen C, Ge J, Chu J, Zhang W, Elledge SJ, Brown M, Liu XS. Mol Cell. 2021 Mar 18;81(6):1292-1308.e11. doi: 10.1016/j.molcel.2021.01.020. Epub 2021 Feb 9. PubMed
The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4(+) T Cells via a Novel CDK8-GATA3-FOXP3 Pathway. Arnett A, Moo KG, Flynn KJ, Sundberg TB, Johannessen L, Shamji AF, Gray NS, Decker T, Zheng Y, Gersuk VH, Rahman ZS, Levy DE, Marie IJ, Linsley PS, Xavier RJ, Khor B. Mol Cell Biol. 2021 Aug 24;41(9):e0008521. doi: 10.1128/MCB.00085-21. Epub 2021 Aug 24. PubMed
GATA3 promotes ferroptosis resistance by repressing integrin beta1 signaling. Karner ER, Wang M, Goel HL, Mercurio AM. Proc Natl Acad Sci U S A. 2025 Aug 26;122(34):e2427304122. doi: 10.1073/pnas.2427304122. Epub 2025 Aug 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.